Current status of the treatment of HER-2 positive breast cancer

Date 05 March 2016
Event ESMO Symposium on Signalling Pathways in Cancer 2016
Session Targeting the EGFR/HER family in breast and gastric cancers
Topics Anticancer Agents
Breast Cancer
Translational Research
Basic Principles in the Management and Treatment (of cancer)
Biological Therapy
Presenter Javier Cortés
Authors C. Zielinski1, J. Cortés2
  • 1Department Of Medicine I And Comprehensive Cancer Center, Medical University Vienna, 1090 - Vienna/AT
  • 2Medical Oncology, Vall d'Hebron Institute of oncology, 08035 - Barcelona/ES